X0306 4 2021-03-08 true 0001586049 Oxford Immunotec Global PLC OXFD 0001384994 Walton Andrew Scott C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM true Ordinary Shares 2021-03-08 4 D 0 4081 22 D 0 D Stock Option (Right to Buy) 8.65 2021-03-08 4 D 0 7457 13.35 D 2026-06-28 Ordinary Shares 7457 0 D Stock Option (Right to Buy) 14.46 2021-03-08 4 D 0 7457 7.54 D 2027-06-06 Ordinary Shares 7457 0 D Stock Option (Right to Buy) 14.49 2021-03-08 4 D 0 7457 7.51 D 2028-06-19 Ordinary Shares 7457 0 D Stock Option (Right to Buy) 14.44 2021-03-08 4 D 0 7457 7.56 D 2029-06-18 Ordinary Shares 7457 0 D Stock Option (Right to Buy) 12.5 2021-03-08 4 D 0 14914 9.5 D 2025-11-04 Ordinary Shares 14914 0 D Stock Option (Right to Buy) 12.5 2021-03-08 4 D 0 7457 9.5 D 2025-11-04 Ordinary Shares 7457 0 D Stock Option (Right to Buy) 12.96 2021-03-08 4 D 0 9494 9.04 D 2030-06-24 Ordinary Shares 9494 0 D Disposed pursuant to the acquisition by PerkinElmer (UK) Holdings Limited of the entire issued share capital of Oxford Immunotec Global PLC on March 8, 2021 by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme"). In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price. Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price. /s/ Matthew T E McLaughlin, as Attorney-in-Fact for Andrew Scott Walton 2021-03-12